Skip to main content
Michael Miller, MD, Cardiology, Fayetteville, NC

Michael J Miller MD

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology


Physician

Join to View Full Profile
  • 3637 Cape Center DrFayetteville, NC 28304

  • Phone+1 910-491-1760

  • Fax+1 910-491-1764

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Michael Miller is a cardiologist based in Asheville NC, with subspecialties in adult peripheral and interventional cardiology. He completed his medical education at the University of Pittsburgh School of Medicine, followed by a residency and fellowship at Duke University Hospital. Dr. Miller has experience in valvular heart disease, cardiac catheterization, peripheral vascular disease, and cardiac critical care.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 1988 - 1991
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1985 - 1988
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1985

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1987 - 2025
  • SC State Medical License
    SC State Medical License 1992 - 2015
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Heart/Stroke Recognition Program National Committee for Quality Assurance, 2010-2013

Press Mentions

  • Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial
    Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical TrialNovember 7th, 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: